Leap Therapeutics Inc
Change company Symbol lookup
Select an option...
LPTX Leap Therapeutics Inc
BAC Bank of America Corp
SLRC Solar Capital Ltd
ORTX Orchard Therapeutics PLC
TOO-E Teekay Offshore Partners LP
TBT ProShares UltraShort 20+ Year Treasury
ASDTX AllianzGI Short Duration High Income Fund
ETR Entergy Corp
ET Energy Transfer LP
ESS Essex Property Trust Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap BlendCompany profile

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1 (DKK1). TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor (GITR). DKN-01 has potential as a targeted cancer treatment in esophageal cancer, cholangiocarcinoma, non-small cell lung cancer, and other tumor types, such as pancreatic, gastric, liver, head and neck, uterine, and prostate cancers and multiple myeloma. It is conducting two clinical trials of TRX518 in patients with advanced solid tumors and have evidence of biomarker modulation and clinical activity. DKN-01 has been tested in a pilot study in patients with multiple myeloma in combination with lenalidomide and dexamethasone. .

Closing Price
$2.08
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
3,700,928
0
  • Prev Close
    2.08
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    3:59p ET 03/21/19
  • Last (size)
    14
  • 52-Wk Range
    1.35 - 10.25
    LowHigh
  • (04/12/18 - 02/04/19)
    54.07%
  • 90.9%
  • Market Cap
    46.3M
  • Shares Outstanding
    22.3M
  • -3.45
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 42.45
  • (% of float 02/28/19)
    2.05

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.